A double blind randomised controlled trial comparing standard dose of iron supplementation for pregnant women with two screen-and-treat approaches using hepcidin as a biomarker for ready and safe to receive iron
Crossref DOI link:
Update policy: https://0-doi-org.brum.beds.ac.uk/10.1007/springer_crossmark_policy
Moore, Sophie E.
Prentice, Andrew M.
Funding for this research was provided by:
Bill and Melinda Gates Foundation
UK MRC and the UK Department for International Development (DFID) under the MRC/DFID Concordant agreement